Contribution of Optical Genome Mapping (OGM) in the Diagnosis of Multiple Congenital Malformations With or Without Intellectual Disability Without Genetic Abnormality
NA
Congenital malformations result from an embryonic or foetal developmental d...
Impact of Optical Genome Mapping in Acute Myeloblastic Leukemia
N/A
A retrospective study using a new technology will be performed: the Optical...
Status
Completed
Location
CHU de Bordeaux, service Hématologie Biologique
Start Date
2023-01-27
Trial ID
NCT05499611
Unified platforM for a Better integRal Evaluation of MyeLodyspLastic Syndromes in SpAin-Strategy for Unraveling Personalized genoMic Medicine in Public heAlth System (UMBRELLA-SUMMA)
N/A
Myelodysplastic Syndromes (MDS) are heterogeneous clonal diseases character...
Status
Recruiting
Location
Fundación Instituto de Investigación Germans Trias i Puyol
Start Date
2024-01-01
Trial ID
NCT06379945
Expanding NGS Data with Optical Genome Mapping (OGM)
NA
Over 50% of pediatric neurological and neurodevelopmental disorders lack a ...
Optical Genome Mapping in Hematological Malignancies
N/A
Establish the diagnostic potential of optical genome mapping in patients wi...
Status
Recruiting
Location
CHRU de Brest
Start Date
2021-09
Trial ID
NCT05009537
Prospective Study to Assess Medical Performance of Optical Mapping and Long Read Sequencing in Detecting Numerical and Structural Chromosome Abnormalities
NA
Chromosomal aberrations are major causes of developmental disorders (Intell...